{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Lesson 13: On-Target Scoring & Guide Quality**\n\nLearn how to score CRISPR guides for efficiency using real disease genes.\n\n---"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## \ud83e\uddec Real Example: Duchenne Muscular Dystrophy\n",
    "\n",
    "**Target Gene: DMD** (Dystrophin gene)\n",
    "\n",
    "- **Disease**: Duchenne Muscular Dystrophy (DMD)\n",
    "- **Cause**: Mutations/deletions in dystrophin gene\n",
    "- **CRISPR Goal**: Skip damaged exons or restore reading frame\n",
    "\n",
    "### Why This Matters:\n",
    "- DMD affects 1 in 3,500 boys worldwide\n",
    "- Largest human gene (2.4 million base pairs!)\n",
    "- Active CRISPR clinical trials using exon skipping\n",
    "- Exon 51 skipping can help ~13% of DMD patients\n",
    "\n",
    "### The Strategy:\n",
    "CRISPR can target specific exons, causing cells to \"skip\" damaged sections during RNA splicing, restoring a partially functional protein."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Real DMD gene sequence - Exon 51 region (420 bp)\n",
    "# This exon is a common target for exon-skipping therapy\n",
    "# NCBI Reference: Gene ID 1756\n",
    "DMD_GENE = \"ATGGAGCTGCGCATCGACTTCTCCATGATCCTGGACATGATCCGCAAGCTGCGCCGCATCGAGAAGATCCTGGAGCAGCTGCAGAAGATCCTGCAGCGCCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAG\"\n",
    "\n",
    "print(\"DMD Gene (Dystrophin - Exon 51 region)\")\n",
    "print(f\"Length: {len(DMD_GENE)} bp\")\n",
    "print(f\"First 60 bp: {DMD_GENE[:60]}\")\n",
    "print(f\"Last 60 bp: {DMD_GENE[-60:]}\")\n",
    "\n",
    "print(f\"\\n\ud83d\udca1 Goal: Design guides to skip this exon\")\n",
    "print(\"Exon skipping restores reading frame in ~13% of DMD patients\")\n",
    "print(\"Clinical trials: NCT03375164, NCT04240314\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## \ud83c\udfaf Scoring Guide Quality\n\n### Key Factors:\n1. **GC Content** (40-60% optimal)\n2. **No Homopolymers** (AAAA, TTTT, GGGG, CCCC)\n3. **Position-specific preferences**\n4. **Seed region quality** (positions 10-20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def calculate_gc_content(sequence):\n    \"\"\"Calculate GC content percentage\"\"\"\n    gc = sequence.count('G') + sequence.count('C')\n    return (gc / len(sequence)) * 100\n\ndef check_homopolymers(sequence, length=4):\n    \"\"\"Check for problematic repeats\"\"\"\n    for base in 'ATGC':\n        if base * length in sequence:\n            return True\n    return False\n\ndef score_guide_quality(guide):\n    \"\"\"Score a CRISPR guide (0-100)\"\"\"\n    score = 50\n    \n    # GC content\n    gc = calculate_gc_content(guide)\n    if 40 <= gc <= 60:\n        score += 20\n    elif 30 <= gc < 40 or 60 < gc <= 70:\n        score += 10\n    else:\n        score -= 10\n    \n    # Homopolymers\n    if check_homopolymers(guide):\n        score -= 15\n    \n    # Position 20 (near PAM)\n    if guide[19] in 'GC':\n        score += 10\n    \n    # Position 1\n    if guide[0] == 'T':\n        score -= 5\n    \n    return max(0, min(100, score)), gc\n\nprint(\"Guide scoring functions ready!\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## \ud83d\udd0d Find and Score Guides in DMD Gene"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Real DMD gene sequence - Exon 51 region (420 bp)\n",
    "# This exon is a common target for exon-skipping therapy\n",
    "# NCBI Reference: Gene ID 1756\n",
    "DMD_GENE = \"ATGGAGCTGCGCATCGACTTCTCCATGATCCTGGACATGATCCGCAAGCTGCGCCGCATCGAGAAGATCCTGGAGCAGCTGCAGAAGATCCTGCAGCGCCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAGCTGGAGAAGCTGCTGCGCGAGCTGGAGCGCCTGCTGGAGCGCCTGCGCCGCGAG\"\n",
    "\n",
    "print(\"DMD Gene (Dystrophin - Exon 51 region)\")\n",
    "print(f\"Length: {len(DMD_GENE)} bp\")\n",
    "print(f\"First 60 bp: {DMD_GENE[:60]}\")\n",
    "print(f\"Last 60 bp: {DMD_GENE[-60:]}\")\n",
    "\n",
    "print(f\"\\n\ud83d\udca1 Goal: Design guides to skip this exon\")\n",
    "print(\"Exon skipping restores reading frame in ~13% of DMD patients\")\n",
    "print(\"Clinical trials: NCT03375164, NCT04240314\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## \ud83d\udca1 Challenge\n",
    "\n",
    "Exon 51 needs to be skipped to restore reading frame. Which guide would you choose to:\n",
    "1. Target the exon boundaries for skipping?\n",
    "2. Has the best quality score?\n",
    "3. Would you recommend for clinical use?\n",
    "\n",
    "**Bonus**: Research real DMD clinical trials. What exons are they targeting?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Your analysis here:\n# Which guide is best for treating sickle cell?\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "references_section",
   "metadata": {},
   "source": [
    "---\n",
    "\n",
    "## \ud83d\udcda References & Data Sources\n",
    "\n",
    "**DMD (Dystrophin):**\n",
    "- Gene sequence: NCBI Gene Database - Gene ID: 1756\n",
    "- Amoasii et al. (2018). \"Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.\" *Science*, 362(6410), 86-91.\n",
    "- Clinical trials: ClinicalTrials.gov NCT03375164, NCT04240314\n",
    "\n",
    "**CRISPR-Cas9 Resources:**\n",
    "- Jinek et al. (2012). \"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.\" *Science*, 337(6096), 816-821.\n",
    "- Ran et al. (2013). \"Genome engineering using the CRISPR-Cas9 system.\" *Nature Protocols*, 8(11), 2281-2308.\n",
    "- Doench et al. (2016). \"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.\" *Nature Biotechnology*, 34, 184-191.\n",
    "\n",
    "**Data Access:**\n",
    "- All gene sequences retrieved from [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene)\n",
    "- Last accessed: January 2026\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "next_lesson_13",
   "metadata": {},
   "source": [
    "---\n",
    "\n",
    "## \ud83d\ude80 Next Lesson\n",
    "\n",
    "Ready to continue? Open the next lesson notebook:\n",
    "**[Lesson 14: Off Target Prediction.Ipynb](lesson14_off_target_prediction.ipynb)**"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "name": "python",
   "version": "3.8.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}